Repetitive transcranial magnetic stimulation (rTMS) of the brain is a noninvasive, well-tolerated technique that can modify cerebral cortex ... rTMS for motor function in Parkinson disease ...

Researchers from Mass General Brigham identified therapeutic targets that may optimize symptom-specific treatment for Parkinson ... connected to the primary motor cortex and cerebellum, while ...

Recently, the researchers identified two distinct subpopulations of mitral/tufted (M/T) cells within the OB that project to the anterior piriform cortex (aPC) and entorhinal cortex (EC). These neural ...

US-based pharmaceutical company AbbVie has reported that the Phase III TEMPO-2 trial of tavapadon, its D1/D5 partial agonist candidate for early-stage Parkinson's disease, met its primary endpoint.